Formulation and Evaluation of Polymeric Nanoparticle by Nano-Precipitation Method
Polymeric nanoparticle as dds
Acyclovir is also known as Acyclovir, this drug is used for treatment of viral infection, particularly for treatment of herpes simplex viral infection. These are taken for month during treatment of herpes simplex viral infection. These are showing the action against all herps virus family. The acyclovir is poorly water-soluble drug. Due to that main aim is to increase the solubility of acyclovir in other solvent. The bioavailability of acyclovir is very less about (15-35%) because it has less oral route absorption. Due to that the acyclovir are given in intravenous route. When acyclovir is taken in oral route, the peak plasma concentration occurs after 1-2 h. The acyclovir having 9-33% of plasma protein binding. The BCS class of acyclovir are Class third (high solubility and Low permeability). Due to that acyclovir are formulate in the form of nanoparticle. Chitosan are the polymers which are used for the formulation of nanoparticle. The chitosan is found to be compatible with acyclovir. Formulation of acyclovir nanoparticle was done by Nano-precipitation method. Many evaluation tests performed during the formulation of Acyclovir nanoparticle mainly zeta sizer is use for the determination of particle size, zeta potential and PDI (poly disperse index) also performed evaluation of loading efficiency and % Drug entrapment.
Keywords: Acyclovir, Chitosan, Zeta sizer and Nanoparticle.
2. Kharia AA, Singhai AK. Formulation and Evaluation of Gastroprotective Drug Delivery System of Acyclovir as Mucoadhesive Nanoparticles. International Journal of PharmTech Research 2013; 5(4):1539-1545.
3. Garg A, Visht S, Sharma PK, Kumar N. Formulation, Characterization and Application on Nanoparticle A Review. Pelagia Research Library 2011; 2(2):17-20.
4. Krishna A, Amareshwar P, Chakrawarty P. Different Technique used for the preparation of Nanoparticle using natural Polymer and Their application. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3(2):45-46.
5. Seetharaman S, Balya H, Kuppusamy G. Preparation and Evaluation of Cefixime Nanoparticles Prepared Using Fenugreek Seed Mucilage and Chitosan as Natural Polymers. International Journal of Pharmaceutical and Clinical Research 2016; 8(3):179-188.
6. Nadaroglu H, Ince S, Alayli A. Synthesis of Nanoparticles by Green Synthesis Method. International Journal of Innovative Research and Reviews 2017; 1(1):6-7.
7. Nagarajan E, Shanmugasundaram P, Ravichandiran V, Vijayalakshmi A, Senthilnathan B, et al. Development and Evaluation of Chitosan Based Polymeric Nanoparticles of an Antiulcer Drug Lansoprazole. Journal of Applied Pharmaceutical Science 2015; 5(4):20-25.
8. Ravi Varma J.N, Kumar S, Prasanthi B, ratna V. Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis. Efficiency for Alveolar Macrophage Targeting; Indian Journal of Pharmaceutical Sciences 2015; 77(3):258-266.
9. Agnieszka Z, Wilczewska, Niemirowicz K, Karolina H, Markiewicz, Car H Nanoparticles as drug delivery systems. Nanoparticles as drug delivery systems 2012; 64:1020-1037.
10. Christian P, Kammer F.V, Baalousha M, Hofmann T. Nanoparticles: structure, properties, preparation and behaviour in environmental media. Ecotoxicology 2008; 2(1):24-26.
11. Heera P, Shanmugam S. Nanoparticle Characterization and Application: An Overview. International Journal of current Microbiology and Applied Science 2015; 4(8):379-386.
12. Hasan S. A Review on Nanoparticles: Their Synthesis and Types. Research Journal of Recent Sciences 2015; 4:1-3.
13. Kaushik A, Sharma HK. Formulation and Evaluation of Cetuximab Loaded Polymeric Nanoparticle. International Journal of pharmaceutical science and research 2019; 10(1):266-271.
14. Betala SN, Varma MM, Abbulu K. Formulation and evaluation of polymeric nanoparticles of an antihypertensive drug for Gastroretention. Journal of Drug Delivery and Therapeutics 2018; 8(6):83-84.
15. Nesalin AJ., Gowthamrajan K, Somasekhara CM (2009) Formulation and Evalution of Nanoparticles containing Flutamide. International Journal of Chemtech Research 2009; 1(4):1331-1334.
16. Abdulla J.M.A. Formulation and Evalution of Rifampicin Loaded Polymeric Nanoparticle for pulmonary Delivery. J.Pharm 2006;5(2):40-42.
17. Mohanraj VJ, Chen Y. Nanoparticles- A Review. Tropical Journal of Pharmaceutical Research 2006;5(1):561-573.
18. Pal SL, Jana U, Manna PK, Mohanta GP, Manavalan R. Nanoparticle: An overview of preparation and characterization. Journal of applied Pharmaceutical Science 2011; 1(06):228-234.
19. Khan I, Saeed k, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry 2019; 12:908-931.
20. Smulders S, Kaiser JP, Zuin S, Landuyt K.L.V, Golanski L et.al. Contamination of nanoparticles by endotoxin: evaluation of different test methods. Particle and Fibre Toxicology 2012; 9(41):2-11.
21. Selvaraj S, Niraimathi V. Formulation and in vivo Evaluation of Acyclovir Loaded Chitosan Nanoparticles for Ocular Delivery. International Journal of Pharmaceutical Sciences and Drug Research 2016; 5(4):619-629.
22. Selvaraj S, Niraimathiand V, Nappinnai M. Formulation and evaluation of acyclovir loaded chitosan nanoparticles. International Journal of Pharmacy and Analytical Research 2017; 9(3):118-125.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).